CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials - PubMed (original) (raw)
Guideline
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
Kenneth F Schulz et al. BMJ. 2010.
Abstract
The CONSORT statement is used worldwide to improve the reporting of randomised controlled trials. Kenneth Schulz and colleagues describe the latest version, CONSORT 2010, which updates the reporting guideline based on new methodological evidence and accumulating experience
Conflict of interest statement
Competing interests: Uniform disclosure of potential conflicts of interest: all authors have completed the ICMJE unified competing interest form at www.icmje.org/coi\_disclosure.pdf (available from the corresponding author) and declare (1) DM received grants for this work from Johnson & Johnson, BMJ, and American Society for Clinical Oncology; KFS and DGA received support for travel to meetings for this work from Johnson & Johnson, BMJ, and American Society for Clinical Oncology; (2) KFS and DA had travel expenses reimbursed by the EQUATOR Network; KFS has received honoraria for delivering educational presentations for the American Board of Obstetrics and Gynecology Foundation for Excellence in Women’s Health Care, Ortho-McNeil Janssen Scientific Affairs, and the American College of Obstetrics and Gynecology; and has done consultancy for Wyeth. All authors also declare (3) no spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; (4) no non-financial interests that may be relevant to the submitted work.
Figures
Flow diagram of the progress through the phases of a parallel randomised trial of two groups (that is, enrolment, intervention allocation, follow-up, and data analysis)
Comment in
- The new CONSORT statement.
Antes G. Antes G. BMJ. 2010 Mar 23;340:c1432. doi: 10.1136/bmj.c1432. BMJ. 2010. PMID: 20332507 No abstract available.
Similar articles
- CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.
Schulz KF, Altman DG, Moher D; CONSORT Group. Schulz KF, et al. J Clin Epidemiol. 2010 Aug;63(8):834-40. doi: 10.1016/j.jclinepi.2010.02.005. Epub 2010 Mar 25. J Clin Epidemiol. 2010. PMID: 20346629 No abstract available. - CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.
Schulz KF, Altman DG, Moher D; CONSORT Group. Schulz KF, et al. BMC Med. 2010 Mar 24;8:18. doi: 10.1186/1741-7015-8-18. BMC Med. 2010. PMID: 20334633 Free PMC article. - CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.
Schulz KF, Altman DG, Moher D; CONSORT Group. Schulz KF, et al. Trials. 2010 Mar 24;11:32. doi: 10.1186/1745-6215-11-32. Trials. 2010. PMID: 20334632 Free PMC article. - CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
Schulz KF, Altman DG, Moher D; CONSORT Group. Schulz KF, et al. Int J Surg. 2011;9(8):672-7. doi: 10.1016/j.ijsu.2011.09.004. Epub 2011 Oct 13. Int J Surg. 2011. PMID: 22019563 No abstract available. - CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG; CONSORT. Moher D, et al. Int J Surg. 2012;10(1):28-55. doi: 10.1016/j.ijsu.2011.10.001. Epub 2011 Oct 12. Int J Surg. 2012. PMID: 22036893 Review.
Cited by
- Enhancing patient outcomes through nursing care in laparoscopic common bile duct exploration; a randomized control trail.
He L, Chen Z, Wang Z, Pan Y. He L, et al. BMC Surg. 2024 Nov 15;24(1):360. doi: 10.1186/s12893-024-02657-z. BMC Surg. 2024. PMID: 39548400 Free PMC article. Clinical Trial. - Effects of clindamycin and amoxycillin as prophylaxis against early implant failure: double-blinded randomized clinical trial.
Pradillo-Gallego D, Manzano-Moreno FJ, Ocaña-Peinado FM, Olmedo-Gaya MV. Pradillo-Gallego D, et al. Clin Oral Investig. 2024 Nov 16;28(12):643. doi: 10.1007/s00784-024-06050-1. Clin Oral Investig. 2024. PMID: 39548015 Clinical Trial. - Effectiveness of proactive health interventions in reducing symptoms and enhancing self-efficacy and self-management in prostate cancer survivors: a randomized controlled trial.
Hou S, Qiao W, Li Y, He H, Wu B, Dai Y, Wang W. Hou S, et al. J Cancer Surviv. 2024 Nov 15. doi: 10.1007/s11764-024-01706-z. Online ahead of print. J Cancer Surviv. 2024. PMID: 39542992 - Effect of Music on Anxiety and Fatigue in Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial.
Gezgin Yazıcı H, Ökten Ç, Karabulut E, Aliustaoğlu M. Gezgin Yazıcı H, et al. Arch Iran Med. 2024 Nov 1;27(11):611-617. doi: 10.34172/aim.31258. Epub 2024 Nov 1. Arch Iran Med. 2024. PMID: 39534995 Free PMC article. Clinical Trial.
References
- Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 2005;365:1159-62. - PubMed
- Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources